Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

DX-88 and HAE: a developmental perspective.

Anthony Williams¹, Lynn G Baird

¹Dyax Inc, 300 Technology Square, Cambridge, MA 02139, USA. twilliams@dyax.com

Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis

|October 24, 2003

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Impact of voxelotor discontinuation on patients with sickle cell disease.

British journal of haematology·2026

Same author

Delirium incidence, risk factors and outcomes in a New Zealand tertiary intensive care unit: a retrospective, observational, single-centre study.

The New Zealand medical journal·2026

Same author

Sensory Circuit Dynamics in a Mouse Model of Epileptic Encephalopathy.

bioRxiv : the preprint server for biology·2025

Same author

SOX2 utilizes FOXA1 as a heteromeric transcriptional partner to drive proliferation in therapy-resistant prostate cancer.

bioRxiv : the preprint server for biology·2025

Same author

Investigating age and ethnicity as novel high-risk phenotypes in mucinous ovarian cancer: retrospective study in a multi-ethnic population.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2025

Same author

Differential DNA Methylation in the Benign and Cancerous Prostate Tissue of African American and European American Men.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2024

Same journal

Therapeutic plasma exchange and immunomodulatory strategies in post-infectious syndromes: A review of immune dysregulation in PTLDS, long COVID, ME/CFS, and PANS/PANDAS.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026

Same journal

Therapeutic plasma exchange in Alzheimer's disease: From clinical trial to real-world evidence.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026

Same journal

Successful treatment of pure red cell aplasia with Orelabrutinib following major ABO-incompatible hematopoietic stem cell transplantation for acute myeloid leukemia: A case report.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026

Same journal

Technological advances in selective plasma adsorption: The MTx.100 column and the emergence of subtractive precision medicine.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026

Same journal

What's happening? Editorial comment: Insights on artificial intelligence, cell therapy and stem cell transplantation safety.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026

Same journal

Red blood cell transfusion in elderly patients: Hemoglobin thresholds and clinical outcomes.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026

See all related articles

A novel drug, DX-88, effectively inhibits plasma kallikrein, offering a promising treatment for Hereditary Angioedema (HAE) attacks. Early studies show a good balance of efficacy and safety for HAE patients.

Area of Science:

Biochemistry
Pharmacology
Immunology

Background:

Hereditary Angioedema (HAE) involves C1 esterase inhibitor deficiency.
Plasma kallikrein is a key mediator in HAE pathogenesis.
Developing targeted therapies for HAE is crucial.

Purpose of the Study:

To explore the developmental approach for novel recombinant products using HAE as a model.
To evaluate DX-88, a novel plasma kallikrein inhibitor, for HAE treatment.

Main Methods:

Phage display technology was used to generate DX-88, a Kunitz domain binder.
DX-88 was investigated as a potent and selective inhibitor of plasma kallikrein.
Early clinical studies assessed the efficacy and safety of DX-88 in HAE patients.

Related Experiment Videos

Main Results:

DX-88 demonstrated potent and selective inhibition of plasma kallikrein.
Early clinical trials indicated a favorable efficacy/safety profile for DX-88.
The drug showed potential in managing acute HAE attacks.

Conclusions:

DX-88 represents a promising novel therapeutic agent for Hereditary Angioedema.
The development of DX-88 highlights the potential of phage display for generating targeted therapeutics.
Further clinical studies are warranted to confirm the long-term efficacy and safety of DX-88 in HAE management.